Taken together, our results showed that metastasis in OS presents low expression of the ERCC2 and MSH2 genes compared with pre-chemotherapy biopsy, which could be related to decreased ability to repair DNA damage in metastasis, possibly resulting in genetic alterations accumulation and more aggressive cancer [25]. This evidence concerns the gene ERCC2 and cancer.